News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioCon Limited (BIOCON.NS) to Sell 7.69% of Research Unit to GE Capital for $23 Million



10/31/2012 8:03:04 AM

Biocon Ltd. (532523.BY) Wednesday said a GE Capital unit will pay 1.25 billion rupees ($23 million) to buy a 7.69% stake in its research services unit, which is looking at conducting an initial public offering.

The GE Capital offer values the research unit -- Syngene International Ltd. -- at 16.25 billion rupees, establishing a "base value" for the company, Biocon Chairman and Managing Director Kiran Mazumdar-Shaw told Dow Jones Newswires.

Read at Fox News


comments powered by Disqus
Fox News
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES